A comparative study of acupuncture mono-therapy and acupuncture and moxibustion combination therapy on chemotherapy-induced peripheral neuropathy symptom

Not Applicable

Recruiting

Conditions: Diseases of the nervous system

Registration Number: KCT0002025

Lead Sponsor: Comprehensive & Integrative Medicine Institute

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 16

Inclusion Criteria

1. People who aged from 20 to 75 years old, the people has been diagnosed with cancer through biopsy or medical imaging at short-term general hospital.
2. People who scored of ECOG performance 0-2
3. People who experienced peripheral neuropathy after chemotherapy.
4. People who complained for more than a month the CIPN
5. People who graded of CTCAE more than 2 point.
6. People who are available the questioinnaire.
7. People who voluntarily signed a informed consent form.
8. People who are able to follow up during the treatment period.
9. People who are not included in the exclusion criteria.

Exclusion Criteria

1. People who has cardiac disease and uncontrollable hypertension
(more than 160/100mmHg)
2. People who are not well controlled diabetic patients
(more than 180mg/dl in fasting blood sugar, more than 250mg/dl in random blood sugar except fasting)
3. People who are impossible to treatment due to infection or injury on the treatment area
4. People who has high risk to infection in acupuncture
Leukopenia (less than 4,000/?) or neutropenia (less than 1,500/?)
5. People who has known blood coagulopathy or taking heparin/coumadin or thrombocytopenia (less than 50,000/?)
6. People who has peripheral neuropathy due to other disorders.
7. People who are using physical therapy, massotherapy and acupuncture within 2 weeks for improve the CIPN.
8. People who are inappropriate in the study.

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease score of the Common Terminology criteria for Adverse Events(CTCAE); Decrease score of Visual Analogue Scale(VAS).

Secondary Outcome Measures

Name	Time	Method
Decrease score of the European Organization for Research and Treatment of Cancer(EORTC) Quality of life questionnaire Chemotherapy-Induced Peripheral Neuropathy 20 (CIPN20).